Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» R/F/TAF
R/F/TAF
Gilead Sciences Spent $125 Million to Get This Drug on the Market 4 Months Early
Motley Fool
Mon, 07/6/15 - 04:28 pm
Gilead Sciences
R/F/TAF
HIV
Gilead Submits New Drug Application to U.S. Food and Drug Administration for Single Tablet Regimen for HIV Containing Rilpivirine, Emtricitabine and Tenofovir Alafenamide (R/F/TAF)
Yahoo
Wed, 07/1/15 - 10:51 pm
Gilead Sciences
HIV
R/F/TAF
FDA